USE OF DERIVATIVES OF N-PHENYLPIPERAZIN-1-YL-ACETAMIDE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF DIABETES RELATED CONDITIONS

摘要

Methods comprising the administration of ranolazine are provided for treating diabetes, lowering plasma level of HbA1c, glucose plasma levels, total cholesterol plasma level, and/or triglyceride plasma level while increasing HDL cholesterol levels and delaying onset of diabetic retinopathy in a diabetic, pre-diabetic, or non-diabetic mammal while minimizing undesirable side effects.